| Jenny Marie Vail-stencel, MA, CCC-SLP | |
|
19814 E Vassar Ave, Aurora, CO 80013-9403 | |
| (720) 353-8939 | |
| Not Available |
| Full Name | Jenny Marie Vail-stencel |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 19814 E Vassar Ave, Aurora, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497908867 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 4093318 (Arizona) | Secondary |
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jenny Marie Vail-stencel, MA, CCC-SLP 19814 E Vassar Ave, Aurora, CO 80013-9403 Ph: (720) 353-8939 | Jenny Marie Vail-stencel, MA, CCC-SLP 19814 E Vassar Ave, Aurora, CO 80013-9403 Ph: (720) 353-8939 |
News Archive
By engineering antibacterial enzymes, Dartmouth investigators led by Karl Griswold, PhD are using novel strategies to target the prevalent drug-resistant bacterium Staphylococcus aureus.
Age alone should not prohibit the use of chemotherapy regimens in older women with breast cancer who are otherwise in good general health, according to a study in the March 2 issue of JAMA.
Baxter International Inc. today announced topline results from a Phase 3 clinical trial evaluating the safety, efficacy and pharmacokinetics (PK) of BAX 111. BAX 111 is a recombinant von Willebrand factor (rVWF) under investigation for the treatment of bleeding episodes in patients with von Willebrand disease, the most common type of inherited bleeding disorder.
A cannibalistic process called autophagy spurs dying embryonic stem cells to send "eat me" and "come get me" signals to have their corpses purged, a last gasp that paves the way for normal mammalian development, UT Southwestern Medical Center researchers have found.
The debate on how to select patients who will respond best to costly drug treatments for aggressive breast cancer now favors fluorescence in situ hybridization (FISH) to measure the HER-2 receptor found in human breast tumors, according to a leading pathologist presenting at the Association for Molecular Pathology annual meeting.
› Verified 7 days ago
Miss Elizabeth Frances Peterson, M.A.,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2600 S Parker Rd Ste 336, Aurora, CO 80014 Phone: 303-330-3309 Fax: 303-862-9770 | |
Rebecca Aragon, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 | |
Kristina Hess, M.A., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 500 Geneva St, Aurora, CO 80010 Phone: 303-364-9311 | |
Elizabeth Marie Cuadrado, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1635 Aurora Court, 6th Floor, Ms F737, Aurora, CO 80045 Phone: 954-735-6000 | |
Cheryl Anselmo, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13123 E 16th Ave, Box 030, Aurora, CO 80045 Phone: 720-777-6085 | |
Mrs. Melanie Lynn Wiseman, M.S. SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 2851 S Parker Rd Ste 570, Aurora, CO 80014 Phone: 303-888-4840 | |
Chloe Mizusawa, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10100 E 13th Ave, Aurora, CO 80010 Phone: 303-366-2671 |